DIHYDROERGOTAMINE MESYLATE
Generic: DIHYDROERGOTAMINE MESYLATE
Gland Pharma LimitedManufacturer
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRoute
DIHYDROERGOTAMINE MESYLATEActive Substance
2023-08-18Original Approval
DIHYDROERGOTAMINE MESYLATE is FDA application ANDA215623, sponsored by GLAND. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
DRUG INEFFECTIVE
353 reports
2
OFF LABEL USE
330 reports
3
HYPERHIDROSIS
323 reports
4
NIGHTMARE
308 reports
5
SEDATION
308 reports
6
NAUSEA
306 reports
7
PRODUCT USE IN UNAPPROVED INDICATION
262 reports
8
NEPHROLITHIASIS
222 reports
9
MIGRAINE
77 reports
10
TREATMENT FAILURE
57 reports